{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:30:20Z","timestamp":1784367020558,"version":"3.55.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Cardiovascular disease (CVD) is a leading cause of death and disability worldwide. Available studies suggest that inflammation and nutritional status play a key role in the development of CVD. As a new combined indicator of inflammation and nutritional status, the neutrophil percentage-to-albumin ratio (NPAR) may be important in CVD prediction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>This study investigated the association between NPAR and CVDs such as heart failure, coronary heart disease, angina pectoris, and stroke. It aimed to confirm the validity of NPAR as a potential biomarker of CVD using data from the National Health and Nutrition Examination Survey (NHANES).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study used a cross-sectional study design that analyzed the neutrophil percentage, albumin levels, and CVD diagnostic information of 12,165 adults. Multifactorial logistic regression modeling was employed to explore the association between NPAR and CVDs such as heart failure, coronary heart disease, angina pectoris, and stroke, while the nonlinear relationships were examined via restricted cubic spline. In addition, subgroup analyses were performed to assess the effect of age, sex, and race on the association between NPAR and CVD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our findings suggested that higher NPAR levels were significantly associated with an increased odds of CVD events. Specifically, each NPAR unit increase was associated with a 3% higher odds of a CVD event (OR\u2009=\u20091.03, 95% CI: 1.01\u20131.06). Individuals in the highest NPAR quartile displayed a significantly higher odds of heart failure (OR\u2009=\u20091.66, 95% CI: 1.18\u20132.34, <jats:italic>p<\/jats:italic>\u2009=\u20090.0035)and stroke (OR\u2009=\u20091.74, 95% CI: 1.28\u20132.36, <jats:italic>p<\/jats:italic>\u2009=\u20090.0004) than those in the lowest quartile. Subgroup analyses showed a more pronounced association between NPAR and CVD in women (OR\u2009=\u20091.04, 95% CI: 1.00\u20131.08, <jats:italic>p<\/jats:italic>\u2009=\u20090.0499), hypertensive patients (OR\u2009=\u20091.04, 95% CI: 1.01\u20131.07, <jats:italic>p<\/jats:italic>\u2009=\u20090.0154), and diabetic patients (OR\u2009=\u20091.05, 95% CI: 1.01\u20131.09, <jats:italic>p<\/jats:italic>\u2009=\u20090.0178).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The study demonstrated that as a comprehensive indicator of inflammation and nutritional status, NPAR could effectively predict CVD occurrence. Although the clinical application value of NPAR requires further validation, it shows promise as a novel biomarker for early CVD screening and prevention.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2025.1557507","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T05:36:40Z","timestamp":1747201000000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["The association between neutrophil percentage-to-albumin ratio and cardiovascular disease: evidence from a cross-sectional study"],"prefix":"10.3389","volume":"12","author":[{"given":"Xinfu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanting","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"B1","article-title":"Cardiovascular diseases (CVDs)","year":"2017"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1253\/circj.CJ-19-0323","article-title":"Effects of tobacco smoking on cardiovascular disease","volume":"83","author":"Kondo","year":"2019","journal-title":"Circ J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12933-018-0703-2","article-title":"Diabetes, cardiovascular disease and the microcirculation","volume":"17","author":"Strain","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12872-023-03185-z","article-title":"Immunity and inflammation in cardiovascular disorders","volume":"23","author":"Boyalla","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.3390\/cells12222647","article-title":"Cardiovascular biomarkers: current Status and future directions","volume":"12","author":"Filipovic","year":"2023","journal-title":"Cells"},{"key":"B9","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.3390\/ijms19123988","article-title":"Nutrition and cardiovascular health","volume":"19","author":"Casas","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejim.2018.04.014","article-title":"Human serum albumin in cardiovascular diseases","volume":"52","author":"Arques","year":"2018","journal-title":"Eur J Intern Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"8137576","DOI":"10.1155\/2020\/8137576","article-title":"Association between neutrophil percentage-to-albumin ratio and all-cause mortality in critically ill patients with coronary artery disease","volume":"2020","author":"Sun","year":"2020","journal-title":"Biomed Res Int"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/resp.14589","article-title":"Predictive role of neutrophil-percentage-to-albumin, neutrophil-to-lymphocyte and eosinophil-to-lymphocyte ratios for mortality in patients with COPD: evidence from NHANES 2011\u20132018","volume":"28","author":"Lan","year":"2023","journal-title":"Respirology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.3390\/cancers14194892","article-title":"Prognostic value of neutrophil percentage-to-albumin ratio in patients with oral cavity cancer","volume":"14","author":"Ko","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrendo.2018.18","article-title":"Global epidemiology of hyperthyroidism and hypothyroidism","volume":"14","author":"Taylor","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B17","first-page":"1","article-title":"National health and nutrition examination survey: sample design, 2011\u20132014","volume":"2","author":"Johnson","year":"2014","journal-title":"Vital Health Stat"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1322971","DOI":"10.3389\/fneur.2024.1322971","article-title":"Assessing the predictive value of neutrophil percentage to albumin ratio for ICU admission in ischemic stroke patients","volume":"15","author":"Zawiah","year":"2024","journal-title":"Front Neurol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.3390\/nu15081892","article-title":"Predictive role of neutrophil-percentage-to-albumin ratio (NPAR) in nonalcoholic fatty liver disease and advanced liver fibrosis in nondiabetic US adults: evidence from NHANES 2017\u20132018","volume":"15","author":"Liu","year":"2023","journal-title":"Nutrients"},{"key":"B20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13075-023-03018-6","article-title":"The association between systemic immune-inflammation index and rheumatoid arthritis: evidence from NHANES 1999\u20132018","volume":"25","author":"Liu","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"B21","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.jacc.2004.07.056","article-title":"Leukocyte count and coronary heart disease: implications for risk assessment","volume":"44","author":"Madjid","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"527","DOI":"10.5551\/jat.60889","article-title":"Leukocyte count and risks of stroke and coronary heart disease: the circulatory risk in communities study (CIRCS)","volume":"29","author":"Li","year":"2022","journal-title":"J Atheroscler Thromb"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5687672","DOI":"10.1155\/2020\/5687672","article-title":"The neutrophil percentage-to-albumin ratio is associated with all-cause mortality in critically ill patients with acute kidney injury","volume":"2020","author":"Wang","year":"2020","journal-title":"Biomed Res Int"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1017\/S0950268820000771","article-title":"Increased neutrophil percentage-to-albumin ratio is associated with all-cause mortality in patients with severe sepsis or septic shock","volume":"148","author":"Gong","year":"2020","journal-title":"Epidemiol Infect"},{"key":"B26","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/MEG.0000000000002470","article-title":"Higher levels of neutrophil percentage-to-albumin ratio predict increased mortality risk in patients with liver cirrhosis: a retrospective cohort study","volume":"35","author":"Du","year":"2023","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1186\/s12872-023-03472-9","article-title":"The neutrophil percentage-to-albumin ratio is associated with all-cause mortality in patients with chronic heart failure","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"B28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.coph.2004.01.002","article-title":"Inflammatory markers and coronary artery disease","volume":"4","author":"Fichtlscherer","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.amjcard.2010.09.039","article-title":"Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure","volume":"107","author":"Uthamalingam","year":"2011","journal-title":"Am J Cardiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"7910","DOI":"10.3390\/ijms24097910","article-title":"Atherosclerosis and inflammation: insights from the theory of general pathological processes","volume":"24","author":"Gusev","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1161\/ATVBAHA.119.313681","article-title":"Plasma albumin and incident cardiovascular disease: results from the CGPS and an updated meta-analysis","volume":"40","author":"Ronit","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"7397","DOI":"10.3390\/ijms24087397","article-title":"Neutrophil-to-lymphocyte ratio is an independent risk factor for coronary artery disease in central obesity","volume":"24","author":"Bagyura","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2147\/JIR.S447750","article-title":"Association of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and coronary artery disease among the physicians","volume":"17","author":"Tangjitgamol","year":"2024","journal-title":"J Inflamm Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.atherosclerosis.2012.09.009","article-title":"Neutrophil\/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography","volume":"225","author":"Arbel","year":"2012","journal-title":"Atherosclerosis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/jcm14010122","article-title":"Relationship between inflammatory readings and the degree of coronary atherosclerosis (pilot study)","volume":"14","author":"Liuiz\u0117 Abramavi\u010di\u016bt\u0117","year":"2024","journal-title":"J Clin Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.hrtlng.2024.11.006","article-title":"Lymphocyte-based inflammatory markers: novel predictors of significant coronary artery disease\u2730,\u2730\u2730","volume":"70","author":"Bani Hani","year":"2025","journal-title":"Heart Lung"},{"key":"B37","doi-asserted-by":"publisher","first-page":"583","DOI":"10.5603\/CJ.a2023.0033","article-title":"Predictive value of systemic inflammatory response index (SIRI) for complex coronary artery disease occurrence in patients presenting with angina equivalent symptoms","volume":"31","author":"Urbanowicz","year":"2024","journal-title":"Cardiol J"},{"key":"B38","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.1093\/eurheartj\/ehad649","article-title":"Neutrophil counts and cardiovascular disease","volume":"44","author":"Luo","year":"2023","journal-title":"Eur Heart J"},{"key":"B39","doi-asserted-by":"publisher","first-page":"9129","DOI":"10.3390\/ijms24119129","article-title":"C-Reactive protein levels and risk of cardiovascular diseases: a two-sample bidirectional Mendelian randomization study","volume":"24","author":"Kuppa","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1557507\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T05:36:41Z","timestamp":1747201001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1557507\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":39,"alternative-id":["10.3389\/fcvm.2025.1557507"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1557507","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"article-number":"1557507"}}